MeiraGTx Holdings plc - Ordinary Shares (MGTX): IPOs News

MGTX – Company has priced 5mm shares at $15.00.

Key Facts Surrounding This News Item

  • MGTX had returned 0.00% year-to-date leading up to today’s news, versus a +4.37% return from the benchmark S&P 500 during the same period.

More Info About MeiraGTx Holdings plc – Ordinary Shares (MGTX)

MeiraGTx Limited develops gene therapies for acquired and inherited disorders. It offers products for neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS); ocular diseases, including rare inherited blindness and age-related macular degeneration (AMD); and xerostomia, a frequent and debilitating side effect of radiation treatment used in head and neck cancers. The company was founded in 2015 and is based in London, United Kingdom. View our full MGTX ticker page with ratings, news, and more.

MGTX at a Glance

MGTX Current POWR Rating™
Overall POWR Rating™
MGTX Current Price $10.31 3.91%
More MGTX Ratings, Data, and News

MGTX Price Reaction

The day of this event (Jun. 7, 2018)
MGTX Closing Price0.00 N/A%
MGTX Volume0
N/A% from avg
Leading up to this event
MGTX 1-mo returnN/A%

MGTX Price Chart

The Top Stocks For 2019

More MeiraGTx Holdings plc - Ordinary Shares (MGTX) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All MGTX News
Page generated in 0.7498 seconds.